Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.67	5.97	2.84	10.06	7.55
Cash & Short-Term Investments	1.67	5.97	2.84	10.06	7.55
Cash Growth	-72.05%	110.54%	-71.80%	33.28%	-30.95%
Accounts Receivable	0.01	-	0.33	0.03	0.1
Other Receivables	0.7	0.7	1.15	1.06	1.38
Receivables	0.72	0.7	1.48	1.1	1.47
Prepaid Expenses	6.43	0.36	0.38	0.61	0.26
Total Current Assets	8.81	7.03	4.69	11.76	9.28
Property, Plant & Equipment	0.32	0.57	0.83	1.15	0.54
Other Intangible Assets	5.65	2.94	0.01	-	-
Total Assets	14.78	10.54	5.53	12.91	9.82
Accounts Payable	0.71	0.31	0.34	0.49	0.34
Accrued Expenses	1.27	0.86	0.82	0.55	0.77
Short-Term Debt	0.43	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.11
Current Portion of Leases	0.18	0.17	0.16	0.15	0.09
Current Income Taxes Payable	0.05	0.06	0.08	0.06	0.03
Current Unearned Revenue	1.47	-	0.2	-	0.07
Other Current Liabilities	0.93	4.17	0.31	0.61	1.59
Total Current Liabilities	5.03	5.57	1.9	1.84	2.99
Long-Term Leases	0.12	0.3	0.46	0.62	0.06
Other Long-Term Liabilities	1.31	-	-	-	0.05
Total Liabilities	6.46	5.86	2.36	2.46	3.1
Common Stock	0.33	1.19	0.11	0.1	0.06
Additional Paid-In Capital	93.12	86.73	83.67	83.43	74.36
Retained Earnings	-150.42	-144.77	-135.34	-127.8	-122.43
Comprehensive Income & Other	65.29	61.52	54.72	54.72	54.72
Shareholders' Equity	8.32	4.68	3.16	10.45	6.72
Total Liabilities & Equity	14.78	10.54	5.53	12.91	9.82
Total Debt	0.73	0.46	0.62	0.77	0.26
Net Cash (Debt)	0.94	5.51	2.21	9.29	7.29
Net Cash Growth	-82.89%	148.96%	-76.19%	27.52%	50.35%
Net Cash Per Share	1.90	174.35	-	-	-
Filing Date Shares Outstanding	2.56	0.18	-	-	-
Total Common Shares Outstanding	0.67	0.12	-	-	-
Working Capital	3.78	1.46	2.79	9.92	6.29
Book Value Per Share	12.45	39.32	-	-	-
Tangible Book Value	2.68	1.74	3.16	10.45	6.72
Tangible Book Value Per Share	4.00	14.60	-	-	-
Machinery	0.77	1.52	1.59	1.87	1.95
Leasehold Improvements	0.05	0.05	0.05	0.05	0

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q